$88.76 0.9%
Price vs. AI Score (Last 150 days)
Data gathered: December 1

Data Bits

Data Bits Value / Change Benchmark
Job Posts 64 -8.6%
Sentiment 69 0%
Webpage traffic 93,000 18.1%
Employee Rating 64 0%
Google Adspend $1,310 -16.6%
Google Trends 24 -53.8%
Linkedin Employees 1,461 N/A
Patents 55 0%
4chan Mentions 0%
Facebook Engagement 7 -12.5%
Facebook followers 2,205 0%
Stocktwits Mentions 1 0%
Stocktwits Subscribers 1,493 0%
Twitter Followers 2,548 -0%
Instagram Followers N/A N/A
News Mentions 0%
Reddit Mentions 0%
ESG 55 0%
Business outlook 48 0%

AI Score

Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

In the news

About iRhythm Technologies

iRhythm is a digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining our wearable biosensing technology with cloud-based data analytics and machine- learning capabilities.

iRhythm Technologies
Price $88.76
Target Price Sign up
Market Cap $2.72B
Dividend Yield 0
Industry Medical & Dental Instruments

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda
Q3 '23125M42M82M-27M-22M
Q2 '23124M38M86M-18M-14M
Q1 '23111M36M76M-39M-34M
Q4 '22113M34M79M-20M-16M
Q3 '22104M33M71M-21M-17M

Insider Transactions

Bobzien Brice filed to sell 18,608 shares at $111.3.
August 10 '23
Patterson Chad filed to sell 30,200 shares at $100.5.
August 2 '23
Turakhia Minang filed to sell 19,719 shares at $103.5.
July 3 '23
Wilson Daniel G. filed to sell 33,847 shares at $103.5.
July 3 '23
Shrishrimal Sumi filed to sell 18,707 shares at $111.5.
June 5 '23
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2023 AltIndex. All rights reserved.